Gene therapy for RPE65-mediated inherited retinal dystrophy completes phase 3

被引:7
|
作者
Lee, Helena [1 ]
Lotery, Andrew [1 ]
机构
[1] Univ Southampton, Fac Med, Clin & Expt Sci, Southampton SO16 6YD, Hants, England
来源
LANCET | 2017年 / 390卷 / 10097期
基金
英国医学研究理事会;
关键词
LEBERS CONGENITAL AMAUROSIS; ADENOASSOCIATED VIRUS; RPE65; MUTATIONS; SAFETY; TRIAL;
D O I
10.1016/S0140-6736(17)31622-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:823 / 824
页数:2
相关论文
共 50 条
  • [21] Early post-approval results of gene therapy for RPE65-mediated retinal dystrophy with Luxturna (voretigene neparvovec) at Massachusetts Eye and Ear
    Rudnick, Noam
    Terrell, David
    Weigel-DiFranco, Carol
    Comander, Jason
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [22] An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK
    Daniel Viriato
    Natalie Bennett
    Raisa Sidhu
    Elizabeth Hancock
    Hannah Lomax
    David Trueman
    Robert E. MacLaren
    Advances in Therapy, 2020, 37 : 1233 - 1247
  • [23] An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK
    Viriato, Daniel
    Bennett, Natalie
    Sidhu, Raisa
    Hancock, Elizabeth
    Lomax, Hannah
    Trueman, David
    MacLaren, Robert E.
    ADVANCES IN THERAPY, 2020, 37 (03) : 1233 - 1247
  • [24] Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
    Russell, Stephen
    Bennett, Jean
    Wellman, Jennifer A.
    Chung, Daniel C.
    Yu, Zi-Fan
    Tillman, Amy
    Wittes, Janet
    Pappas, Julie
    Elci, Okan
    McCague, Sarah
    Cross, Dominique
    Marshall, Kathleen A.
    Walshire, Jean
    Kehoe, Taylor L.
    Reichert, Hannah
    Davis, Maria
    Raffini, Leslie
    George, Lindsey A.
    Hudson, F. Parker
    Dingfield, Laura
    Zhu, Xiaosong
    Haller, Julia A.
    Sohn, Elliott H.
    Mahajan, Vinit B.
    Pfeifer, Wanda
    Weckmann, Michelle
    Johnson, Chris
    Gewaily, Dina
    Drack, Arlene
    Stone, Edwin
    Wachtel, Katie
    Simonelli, Francesca
    Leroy, Bart P.
    Wright, J. Fraser
    High, Katherine A.
    Maguire, Albert M.
    LANCET, 2017, 390 (10097): : 849 - 860
  • [25] Vitreous degeneration in patients treated with subretinal gene therapy for RPE65-associated inherited retinal dystrophy
    van Overdam, K. A.
    van den Born, L. I.
    ACTA OPHTHALMOLOGICA, 2023, 101 : 44 - 45
  • [27] Subretinal deposits in young patients treated with voretigene neparvovec-rzyl for RPE65-mediated retinal dystrophy
    Lopez, Jennifer
    Borchert, Mark
    Lee, Thomas C.
    Nagiel, Aaron
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2023, 107 (03) : 299 - 301
  • [28] Longitudinal characterization of chorioretinal atrophies after subretinal gene augmentation therapy with Voretigene Neparvovec in RPE65-mediated retinal degeneration
    Kuenzel, Sandrine
    Sassmannshausen, Marlene
    Sassen, Josua
    Preising, Markus
    Holz, Frank
    Lorenz, Birgit
    Herrmann, Philipp
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [29] A systematic review of economic evaluations for RPE65-mediated inherited retinal disease including HTA assessment of broader value
    Farris, Maria
    Goodall, Stephen
    Lourenco, Richard De Abreu
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2023, 39 (01)
  • [30] The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 Gene
    Chung, Daniel C.
    Bertelsen, Mette
    Lorenz, Birgit
    Pennesi, Mark E.
    Leroy, Bart P.
    Hamel, Christian P.
    Pierce, Eric
    Sallum, Juliana
    Larsen, Michael
    Stieger, Knut
    Preising, Markus
    Weleber, Richard
    Yang, Paul
    Place, Emily
    Liu, Emily
    Schaefer, Grace
    Distefano-Pappas, Julie
    Elci, Okan U.
    Mccague, Sarah
    Wellman, Jennifer A.
    High, Katherine A.
    Reape, Kathleen Z.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 199 : 58 - 70